Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platforms

CANCER

WILEY

1. Agency for Healthcare Research and Quality [K12HS023011, R34AT009447, R21CA226671]
2. American Cancer Society, the Melanoma Research Alliance
3. Bristol-Myers Squibb [MRAP-18-112-01-CPHPS]
4. National Center for Complementary and Integrative Health
5. Northwestern University Robert H. Lurie Comprehensive Cancer Center development funds [NCI CCSG P30 CA060553]